An additional "booster" dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a study by researchers at the Ragon ...
Jan 6, 2022
1
392
From income to housing to addressing racism and more, a new guideline proposes 13 ways to address inequities exposed and worsened by COVID-19 in the pandemic recovery period. The guidance is published in CMAJ (Canadian Medical ...
Dec 13, 2021
0
1
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine ...
Aug 26, 2021
3
4034
(HealthDay)—Parents need to know that COVID-19 shots are safe and effective for kids age 12 and older, an expert says.
Jun 14, 2021
0
1
In a new study, Johns Hopkins Medicine researchers have tried to address recent reports that sudden sensorineural hearing loss—a condition that occurs as a result of damage to the inner ear—has been suspected of being ...
Jun 4, 2021
0
3
COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease. New research from Cedars-Sinai ...
Mar 18, 2021
0
8
(HealthDay)—Now that federal guidelines have expanded COVID-19 vaccine eligibility to include people over 65 and those of all ages with underlying health conditions, drug stores say they are ready, willing and able to start ...
Jan 15, 2021
1
5
Gwinnett County Transit driver Mikesha Walker talked to co-workers recently about whether they would participate in a COVID-19 vaccine research trial.
Sep 11, 2020
0
2
(HealthDay)—In the race to find treatments for COVID-19, the antiviral drug remdesivir has gotten much of the attention. But researchers say a class of long-used drugs called interferons also looks promising.
May 15, 2020
0
9
A large international research collaboration, led by an academic from Royal Holloway, University of London, found that blood groups could help predict the risk of venous strokes associated with the Oxford-AstraZeneca COVID-19 ...
Dec 14, 2023
0
25
